Whole-genome fingerprint of the DNA methylome during human B cell differentiation M Kulis, A Merkel, S Heath, AC Queirós, RP Schuyler, G Castellano, ... Nature genetics 47 (7), 746-756, 2015 | 315 | 2015 |
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia R Beekman, V Chapaprieta, N Russiñol, R Vilarrasa-Blasi, ... Nature medicine 24 (6), 868-880, 2018 | 188 | 2018 |
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes F Nadeu, D Martin-Garcia, G Clot, A Díaz-Navarro, M Duran-Ferrer, ... Blood, The Journal of the American Society of Hematology 136 (12), 1419-1432, 2020 | 168 | 2020 |
Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage AC Queiros, R Beekman, R Vilarrasa-Blasi, M Duran-Ferrer, G Clot, ... Cancer cell 30 (5), 806-821, 2016 | 143 | 2016 |
Molecular map of chronic lymphocytic leukemia and its impact on outcome BA Knisbacher, Z Lin, CK Hahn, F Nadeu, M Duran-Ferrer, KE Stevenson, ... Nature genetics 54 (11), 1664-1674, 2022 | 80 | 2022 |
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ... Nature medicine 28 (8), 1662-1671, 2022 | 78 | 2022 |
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics F Nadeu, R Royo, G Clot, M Duran-Ferrer, A Navarro, S Martín, J Lu, ... Blood, The Journal of the American Society of Hematology 137 (21), 2935-2946, 2021 | 63 | 2021 |
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome M Duran-Ferrer, G Clot, F Nadeu, R Beekman, T Baumann, J Nordlund, ... Nature Cancer 1 (11), 1066-1081, 2020 | 55 | 2020 |
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma R Ordoñez, M Kulis, N Russiñol, V Chapaprieta, A Carrasco-Leon, ... Genome research 30 (9), 1217-1227, 2020 | 40 | 2020 |
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features P Robbe, KE Ridout, DV Vavoulis, H Dréau, B Kinnersley, N Denny, ... Nature genetics 54 (11), 1675-1689, 2022 | 30 | 2022 |
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia N Papakonstantinou, S Ntoufa, M Tsagiopoulou, T Moysiadis, S Bhoi, ... International journal of cancer 144 (11), 2695-2706, 2019 | 26 | 2019 |
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy M Tsagiopoulou, N Papakonstantinou, T Moysiadis, L Mansouri, ... Clinical Epigenetics 11, 1-12, 2019 | 17 | 2019 |
Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation M Tsagiopoulou, V Chapaprieta, M Duran-Ferrer, T Moysiadi, ... Haematologica 105 (12), 2864, 2020 | 15 | 2020 |
In silico deconvolution and purification of cancer epigenomes M Duran-Ferrer, R Beekman, JI Martín-Subero Oncoscience 4 (3-4), 25, 2017 | 7 | 2017 |
The CLL-1100 project: towards complete genomic characterization and improved prognostics for CLL BA Knisbacher, Z Lin, CK Hahn, F Nadeu, M Duran-Ferrer, KE Stevenson, ... Blood 136, 3-4, 2020 | 5 | 2020 |
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases A Carbo-Meix, F Guijarro, L Wang, M Grau, R Royo, G Frigola, ... Haematologica 109 (2), 493, 2024 | 4 | 2024 |
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms EM Fernández-Garnacho, F Nadeu, S Martín, P Mozas, A Rivero, ... Scientific Reports 13 (1), 16839, 2023 | 3 | 2023 |
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia C Syrykh, B Pons-Brun, N Russiñol, H Playa-Albinyana, T Baumann, ... Blood Advances 7 (23), 7384-7391, 2023 | 2 | 2023 |
S843 THE PROLIFERATIVE HISTORY SHAPES THE DNA METHYLOME OF B‐CELL TUMORS AND PREDICTS CLINICAL OUTCOME M Duran‐Ferrer, G Clot, F Nadeu, R Beekman, T Baumann, J Nordlund, ... HemaSphere 3, 376, 2019 | 2 | 2019 |
Epigenomic characterization of lymphoid neoplasms M Duran-Ferrer, JI Martín-Subero Annual Review of Pathology: Mechanisms of Disease 19 (1), 371-396, 2024 | 1 | 2024 |